Glimepiride-d4-2

• Description:

  Glimepiride-d4-2 (GliAmperide-d4-2) is deuterium labeled Glimepiride. Glimepiride (Glimperide) is a medium-to-long acting sulfonylurea anti-diabetic compound with an ED50 of 182 μg/kg.

• Product Name Alternative:

  Glimperide-d4-2; HOE-490-d4-2

• UNSPSC:

  12352005

• Target:

  Amyloid-β; Isotope-Labeled Compounds

• Related Pathways:

  Neuronal Signaling; Others

• Applications:

  Neuroscience-Neurodegeneration

• Field of Research:

  Metabolic Disease

• Smiles:

  C[C@H](CC1)CC[C@@H]1NC(NS(C(C([2H])=C2[2H])=C([2H])C([2H])=C2CCNC(N3C(C(CC)=C(C3)C)=O)=O)(=O)=O)=O

• Molecular Formula:

  C24H30D4N4O5S

• Molecular Weight:

  494.64

• References & Citations:

  [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Geisen, K., Special pharmacology of the new sulfonylurea glimepiride. Arzneimittelforschung, 1988. 38 (8) : p. 1120-30.|[3]Liu, F., et al., Glimepiride attenuates Abeta production via suppressing BACE1 activity in cortical neurons. Neurosci Lett, 2013. 557 Pt B: p. 90-4.|[4]Basit, A., M. Riaz, and A. Fawwad, Glimepiride: evidence-based facts, trends, and observations (GIFTS) . [corrected]. Vasc Health Risk Manag, 2012. 8: p. 463-72.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Isotope-Labeled Compounds

• Clinical Information:

  No Development Reported

• CAS Number:

  [1131981-32-2]